JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES)

• Articles • Previous Articles     Next Articles

Polystyrene sulfonic lanthanum in the treatment of hyperphosphatemia in rats with chronic renal failure

PAN Ming-ming, MIAO Hua, HONG Hong, ZHU Zhu-xian   

  1. Kidney and Hemodialiysis Center, Shandong Qianfoshan Hospital, School of Clinical Medicine, Shandong University, Jinan 250012, Shandong, China
  • Received:2007-01-29 Revised:1900-01-01 Online:2007-09-24 Published:2007-09-24
  • Contact: MIAO Hua

Abstract: Objective: To explore the effect of polystyrene sulfonic lanthanum on hyperphosphatemia in chronic renal failure induced by adenine. Methods: Ninety male Waster rats were fed adenine 300mg/kg·d for 15 days and were divided into five groups. The first three groups were fed 1.5g/(kg·d), 0.75g/(kg·d) and 0.375g/(kg·d) polystyrene sulfonic lanthanum, the fourth group was fed calcium carbonate and the fifth group had no drug. Feeding with adenine continued for 10 days in each group and with the corresponding drugs for 22 days. The weight and serum Ca, P, BUN, Scr, RBC, Hb, PLT and HCT were determined. At 22 days, the rats were killed and the kidneys were used!for analysis. Results: The serum phosphorus level was significantly decreased in the group fed polystyrene sulfonic lanthanum of 1.5g/kg per day compared with the normal group [(2.47±0.38)mmol/l vs (3.46±1.15)mmol/l](P<0.05). However, the serum calcium level was significantly increased in the calcium carbonate group compared with the normal group [(3.48±0.40)mmol/l vs (2.79±0.16)mmol/l](P<0.01). Conclusion: High dose polystyrene sulfonic lanthanum could efficiently reduce serum phosphorus levels in rats with chronic renal failure induced by adenine.

Key words: Polystyrene, Sulfonic lanthanum, Renal failure, chronic, Phosphorus

CLC Number: 

  • R733.4
[1] LU Chenlin, XU Lu, YANG Junfa, PAN Huaqin, NI Qingtao. Construction and validation of a risk prediction model for pulmonary encephalopathy associated with acute exacerbation of chronic obstructive pulmonary disease based on dynamic nomogram and machine learning [J]. Journal of Shandong University (Health Sciences), 2026, 64(3): 108-115.
[2] WANG Jianmin, LI Xiaofeng, YOU Zhitao, DONG Shengjie, ZHAO Yuchi, LI Zhanju, ZOU Dexin, ZHANG Jianfeng, SUN Tao, DU Wei. Construction of a chronic post-surgical pain prediction model for posterior lumbar interbody fusion surgery based on interpretable machine learning [J]. Journal of Shandong University (Health Sciences), 2026, 64(2): 78-88.
[3] ZHANG Mingyu, GAO Shijuan, PAN Dongjie, WANG Chunxia, WANG Haipeng, LI Hui. Potentially inappropriate medication of patients with multiple chronic diseases in rural areas of Shandong Province [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 75-81.
[4] JIA Kui, LI Zhiguo, CHENG Cuiting, LI Zhijuan, LIU Ruiqing. Efficacy and mechanism of ginkgo leaf tablets combined with trimetazidine in the treatment of elderly patients with chronic heart failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 19-26.
[5] JIA Ruoxi, LYU Li, LIU Hanyun, WU Yinping, LI Fengcai, ZHAO Zehua, WANG Kai, FAN Yuchen. Diagnostic value of blood cell count-related biomarkers in predicting 28-day mortality in acute-on-chronic hepatitis b liver failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 89-99.
[6] CAI Jiaying, WANG Jingting, WANG Zengping, WANG Jing, JIA Yanfei, MA Xiaoli. Effect of α5-nAChR on the expression of c-Fos in nucleus ambiguus in chronic stress-induced lung adenocarcinoma mice [J]. Journal of Shandong University (Health Sciences), 2025, 63(4): 69-74.
[7] YANG Chuntao, ZUO Yu. Causal relationship of MMP1 and MMP9 genes with chronic periodontitis: an exploratory study based on two-sample Mendelian randomization [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 87-97.
[8] SHAN Tixiao, DU Weichen, WANG Qinzhou, LI Anning, LI Chunhai. Research progress of magnetic resonance imaging in autoimmune nodopathies [J]. Journal of Shandong University (Health Sciences), 2025, 63(11): 117-122.
[9] WU Qiqi, CHENG Miaomiao, XIAO Xiaoyan. Multimodal models in the field of kidney disease [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 117-124.
[10] GUO Yantong, YU Yuanyuan, CHEN Yingying, FU Yu, ZHANG Botao, YUAN Ying, SUN Shuangshuang, ZHAO Yingqi, ZHU Gaopei, XUE Fuzhong. Current situation and influencing mechanism of knowledge, attitude and practice about chronic disease management among elderly people in Shandong Provinces proactive health demonstration area [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 98-105.
[11] WANG Fengyan, LIANG Zhenyu, LI Xueping, CHEN Rongchang. Clinical research hotspots of chronic obstructive pulmonary disease in recent years [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 7-15.
[12] SHEN Yongchun, WEN Fuqiang. Research progress of mitochondrial damage-associated molecular patterns as biomarkers for chronic obstructive pulmonary disease [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 16-20.
[13] YANG Xueyan, WU Yinping, LYU Li, ZHAO Zehua, MA Hangyu, LI Fengcai, WANG Kai, FAN Yuchen. Diagnostic value of dynamic changes of monocyte-to-lymphocyte ratio in acute-on-chronic hepatitis B liver failure [J]. Journal of Shandong University (Health Sciences), 2024, 62(3): 61-69.
[14] CAO Yuan, ZHANG Jianqiao, MENG Xiangwei, LIU Wen, PANG Xiaoming. Current status of drug clinical research for the treatment of chronic rhinosinusitis with nasal polyps in China [J]. Journal of Shandong University (Health Sciences), 2024, 62(12): 38-42.
[15] HAO Yan, CUI Limei, CHEN Ying, YANG Yujuan, SONG Xicheng. Advances of metabolomics in airway inflammatory diseases [J]. Journal of Shandong University (Health Sciences), 2024, 62(12): 117-124.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!